Search Grant Opportunities

NHLBI TOPMed: Omics Phenotypes of Heart, Lung, and Blood Disorders (X01 - Clinical Trial Not Allowed)

ID: PAR-25-447 • Type: Posted
Opportunity Assistant

Hello! Please let me know your questions about this opportunity. I will answer based on the available opportunity documents.

Sign in to upload a capability statement or catalogue for your company

Some suggestions:
Please summarize the work to be completed under this opportunity
Who is eligible to apply for this grant?
I'd like to anonymously submit a question to the procurement officer(s)
Loading

Description

Posted: Sept. 22, 2025, 12:00 a.m. EDT
This Notice of Funding Opportunity (NOFO) invites applications to use NHLBI-funded TransOmics for Precision Medicine (TOPMed) program to generate a large volume of integrated genetic and multi-omics data to facilitate discovery of the molecular mechanisms of Heart, Lung, Blood, and Sleep (HLBS) disorders. No funding will be provided under this NOFO. The genomic data and related phenotypic data will be deposited in a public NIH-designated controlled-access database such as the database for Genotypes and Phenotypes (dbGaP) and NHLBIs BioData Catalyst (BDC). The overall goal is to move from simply cataloguing genetic associations to understanding how genetic factors contribute to HLBS diseases at the molecular and cellular levels. This transformation will help move TOPMed from genetic Map to Mechanism with potential applications of AI and ML tool sets where possible, enabling functional genomics research that will accelerate mechanistic personalized medicine
Posted: July 8, 2025, 12:00 a.m. EDT
Posted: July 8, 2025, 12:00 a.m. EDT
Posted: July 8, 2025, 12:00 a.m. EDT
Background
The National Heart, Lung, and Blood Institute (NHLBI) provides global leadership in research, training, and education to promote the prevention and treatment of heart, lung, blood, and sleep disorders. The NHLBI's mission encompasses many common diseases such as heart disease and chronic respiratory diseases, which are leading causes of death in the US and worldwide. The NHLBI also supports research on rare and complex diseases.

The TransOmics for Precision Medicine (TOPMed) program was established to generate large-scale genomics data for the research community to enable the study of molecular mechanisms underlying HLBS disorders. This NOFO invites applications to utilize TOPMed resources to generate integrated genetic and multi-omics data aimed at understanding HLBS disorders at molecular levels.

Grant Details
This NOFO invites applications to access TOPMed capacity to generate a large volume of integrated genetic and multi-omics data. The genomic data and related phenotypic data will be deposited in public NIH-designated controlled-access databases such as dbGaP and NHLBI's BioData Catalyst (BDC). Applicants are expected to participate in TOPMed data-sharing, integrate existing high-quality biospecimens from well-phenotyped human subjects, and focus on generating whole genome sequencing (WGS) data. Applications should address specific knowledge gaps relevant to HLBS disorders, including common diseases and rare diseases like Sickle Cell disease. All omics data must be shared with the broader research community through designated databases.

Eligibility Requirements
Eligible applicants include higher education institutions, nonprofits, for-profit organizations, local governments, state governments, tribal governments, foreign organizations, and other entities as specified in the eligibility section. Applicants must ensure that all human subjects used in their applications are appropriately consented for data-sharing.

Period of Performance
The maximum project period is 3 years.

Grant Value
No funding will be provided under this NOFO; it is a resource access award with no budget applicable.

Overview

On 9/22/25 the National Institutes of Health posted grant opportunity PAR-25-447 for NHLBI TOPMed: Omics Phenotypes of Heart, Lung, and Blood Disorders (X01 - Clinical Trial Not Allowed). The grant will be issued under grant program 93.233 National Center on Sleep Disorders Research.

Timing

Posted Date
Sept. 22, 2025, 12:00 a.m. EDT
Closing Date
May 8, 2028, 12:00 a.m. EDT Due in 787 Days
Last Updated
Sept. 23, 2025, 9:51 a.m. EDT
Version
1
Archive Date
June 13, 2028

Eligibility

Eligible Applicants
Public housing authorities/Indian housing authorities
Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
Independent school districts
City or township governments
Special district governments
Small businesses
Public and State controlled institutions of higher education
Native American tribal organizations (other than Federally recognized tribal governments)
County governments
Native American tribal governments (Federally recognized)
Private institutions of higher education
Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
For profit organizations other than small businesses
State governments
Others (see text field entitled "Additional Information on Eligibility" for clarification)
Additional Info
Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession.

Contacts

Contact
National Institutes of Health
Contact Email
Email Description
See Section VII. Agency Contacts within the full opportunity announcement for all other inquires.
Contact Phone
(301) 402-2541
Additional Information
https://grants.nih.gov/grants/guide/pa-files/PAR-25-447.html

Documents

Posted documents for PAR-25-447

Potential Applicants and Partners

Awardees that have recently won grants similar to PAR-25-447

Incumbent or Similar Grants

Grants similar to PAR-25-447

Similar Active Opportunities

Open grant opportunities similar to PAR-25-447

Experts for NHLBI TOPMed: Omics Phenotypes of Heart, Lung, and Blood Disorders (X01 - Clinical Trial Not Allowed)

Recommended subject matter experts available for hire